Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 6, 2012, Pages 3402-3405

  Tsai, Hsih Yeh ^a   Liao, Chun Hsing ^a   Chen, Yen Hsu ^b,c   Lu, Po Liang ^b,c   Huang, Cheng Hua ^d   Lu, Chin Te ^e   Chuang, Yin Ching ^f   Tsao, Shih Ming ^g,h   Chen, Yao Shen ^i,j   Liu, Yung Ching ^i,j   Chen, Wei Yu ^k   Jang, Tsrang Neng ^k   Lin, Hsiu Chen ^l   Chen, Chih Ming ^m   Shi, Zhi Yuan ⁿ   Pan, Sung Ching ^o   Yang, Jia Ling ^o   Kung, Hsiang Chi ^o   Liu, Chun Eng ^p   Cheng, Yu Jen ^p   Liu, Jien Wei ^q   Sun, Wu ^r   Wang, Lih Shinn ^s   Ko, Wen Chien ^t   Yu, Kwok Woon ^u   Chiang, Ping Cherng ^v   Lee, Ming Hsun ^v   Lee, Chun Ming ^w   Hsu, Gwo Jong ^x   Hsueh, Po Ren ^o   more..

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e LOTUNG POH AI HOSPITAL   (Taiwan)

^f CHI MEI MEDICAL CENTER   (Taiwan)

^g CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^h University Hospital   (Taiwan)

ⁱ TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^j KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^k SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^l TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^m TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

ⁿ TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^o NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^p CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^q CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^r Pao Chien Hospital   (Taiwan)

^s BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^t NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^u TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^v Chang Gung Medical Foundation Linkou Branch   (Taiwan)

^w MACKAY MEMORIAL HOSPITAL   (Taiwan)

^x CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; LINEZOLID; TIGECYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM;

ACETAMIDES; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECIUM; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MOLECULAR EPIDEMIOLOGY; OXAZOLIDINONES; TAIWAN; VANCOMYCIN RESISTANCE;

EID: 84861175342     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00533-12     Document Type: Article

References (24)

1. Ben RJ, et al. 1996. Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan. J. Formos. Med. Assoc. 95:946-949.
2. Bonten MJM, Willems R, Weinstein RA. 2001. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect. Dis. 1:314-325. (Pubitemid 33586612)
3. Bourdon N, et al. 2011. Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08. J. Antimicrob. Chemother. 66:713-721.
4. Cetinkaya Y, Falk P, Mayhall CG. 2000. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13:686-707.
5. Chen YH, et al. 2012. Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the tigecycline in vitro surveillance in Taiwan study, 2006 to 2010. Antimicrob. Agents Chemother. 56:1452-1457.
6. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Grayson ML, et al. 1991. Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob. Agents Chemother. 35:2180-2184.
8. Hsieh YC, Lee WS, Ou TY, Hsueh PR. 2010. Clonal spread of CC17 vancomycin-resistant Enterococcus faecium with multilocus sequence type 78 (ST78) and a novel ST444 in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 29:25-30.
9. Hsueh PR, et al. 1999. Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect. Control Hosp. Epidemiol. 20:828-833.
10. Hsueh PR, Chen WH, Teng LJ, Luh KT. 2005. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycinresistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int. J. Antimicrob. Agents 26:43-49.
11. Huang YT, Liao CH, Teng LJ, Hsueh PR. 2008. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Clin. Microbiol. Infect. 14:124-129.
12. Kelesidis T, Humphries R, Uslan DZ, Pegues DA. 2011. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin. Infect. Dis. 52:228-234.
13. King EA, McCoy D, Desai S, Nyirenda T, Bicking KK. 2011. Vancomycin- resistant enterococcal bacteraemia and daptomycin: are higher doses necessary? J. Antimicrob. Chemother. 66:2112-2118.
14. Lai CC, et al. 2011. Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare- associated infections at a university hospital in Taiwan from 2000 to 2009. Eur. J. Clin. Microbiol. Infect. Dis. 30:265-271.
15. Lo WT, et al. 2011. Changing trends in antimicrobial resistance of major bacterial pathogens, 1985-2005: a study from a medical center in northern Taiwan. J. Microbiol. Immunol. Infect. 44:131-138.
16. Murray BE. 1990. The life and times of the Enterococcus. Clin. Microbiol. Rev. 3:46-65. (Pubitemid 20078774)
17. Murray BE. 2000. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342:710-721. (Pubitemid 30131425)
18. Rathe M, Kristensen L, Ellermann-Eriksen S, Thomsen MK, Schumacher H. 2010. Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin. APMIS 118:66-73.
19. Sader HS, Moet GJ, Farrell DJ, Jones RN. 2011. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillinresistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). Diagn. Microbiol. Infect. Dis. 70:412-416 .
20. Sader HS, Streit JM, Fritsche TR, Jones RN. 2006. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Clin. Microbiol. Infect. 12:844-852. (Pubitemid 44151284)
21. Salgado CD, Farr BM. 2003. Outcomes associated with vancomycinresistant enterococci: a meta-analysis. Infect. Control Hosp. Epidemiol. 24:690-698. (Pubitemid 37221342)
22. Tseng SH, Lee CM, Lin TY, Chang SC, Chang FY. 2011. Emergence and spread of multi-drug resistant organisms: think globally and act locally. J. Microbiol. Immunol. Infect. 44:157-165.
23. Uttley AH, Collins CH, Naidoo J, George RC. 1988. Vancomycinresistant enterococci. Lancet i:57-58.
24. Wang JL, Hsueh PR. 2009. Therapeutic options for infections due to vancomycin-resistant enterococci. Expert Opin. Pharmacother. 10:785-796.